Thursday, March 20, 2025 3:50:56 PM
And as longtime bag holders continue to be weary, more and more will be inclined to bail at that .002 level rather than sit and wait.
Don't get me wrong, I continue to see a lot of promise, and think that ultimately there will be some upside here. But it's definitely a challenge to determine when that upside might materialize, and when it's more prudent to cash in your chips and walk away.
Don't get me wrong, I continue to see a lot of promise, and think that ultimately there will be some upside here. But it's definitely a challenge to determine when that upside might materialize, and when it's more prudent to cash in your chips and walk away.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
